The economics of patents and innovation in pharma Book chapter Feb 22 Written by Matthijs Versteegh Matthijs Versteegh Previous Previous The value of health in a cost-effectiveness analysis: theory vs practice Next Next Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib
The economics of patents and innovation in pharma Book chapter Feb 22 Written by Matthijs Versteegh Matthijs Versteegh
